类有机物
转录组
生物
癌症研究
胰腺癌
计算生物学
限制
表型
肿瘤异质性
仿形(计算机编程)
基因表达谱
遗传异质性
胰腺导管腺癌
腺癌
肿瘤微环境
细胞
精密医学
胰腺
肿瘤异质性
病理
吉西他滨
作者
Subin Choi,Yejin Youm,Inki Kim,Eunsung Jun,Hwa‐Rim Lee,Sungjune Jung
标识
DOI:10.1088/1758-5090/aec2ac
摘要
Abstract Pancreatic ductal adenocarcinoma (PDAC) exhibits extensive intratumoral heterogeneity that contributes to therapeutic resistance and disease recurrence. However, conventional bulk analyses often obscure the molecular and functional diversity of individual tumor cell populations, limiting the identification of rare drug-resistant populations. Here, we present a high-resolution, drop-on-demand inkjet bioprinting platform for generating single cell-derived PDAC organoids to systematically investigate clonal heterogeneity. Using this platform, we generated over 600 organoids and characterized substantial variations in morphology, growth kinetics, protein expression, and chemotherapeutic responses. Transcriptomic profiling of 30 individual organoids further revealed pronounced molecular heterogeneity, even among organoids assigned to the same morphological subtype. Notably, morphology-based classification into classical and basal-like subtypes did not consistently correspond to transcriptomic signatures, demonstrating that morphological similarity does not necessarily reflect molecular similarity. Furthermore, individual organoids exhibited heterogeneous responses to gemcitabine and nab-paclitaxel, including highly resistant organoids whose responses were obscured by subtype-averaged analyses. Together, these findings establish an inkjet-based clonal organoid platform that integrates controlled single-cell deposition with molecular profiling and longitudinal drug-response analysis, enabling systematic characterization of morphological, molecular, and functional heterogeneity at the individual organoid level.
科研通智能强力驱动
Strongly Powered by AbleSci AI